US Patent Issued to SHANGHAI RAISING PHARMACEUTICAL on March 17 for "Application of TPK as a target in Alzheimer's disease" (Chinese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,575,549, issued on March 17, was assigned to SHANGHAI RAISING PHARMACEUTICAL Co. LTD. (Shanghai).

"Application of TPK as a target in Alzheimer's disease" was invented by Chunjiu Zhong (Shanghai), Shaoming Sang (Shanghai), Jingjing Wang (Shanghai) and Huan Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is use of thiamine pyrophosphokinase TPK as a target in the treatment of Alzheimer's disease; and AD symptoms due to the inhibited TPK can be prevented by promoting the kinase activity and/or expression level of TPK protein in brain with TPK as a target."

The patent was filed on Feb. 2, 2022, under Application No. 17/591,379.

*F...